Howard G. Smith

ProAssurance

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of ProAssurance Corporation Investors | Malvern Daily Record | 1/29/2020

Law Offices of Howard G. Smith continues its investigation on behalf of ProAssurance Corporation (“ProAssurance” or the “Company”) (NYSE: PRA ) investors concerning the Company and its officers’ possible violations of federal securities laws. On January 22, 2020, after the market closed, ProAssurance disclosed a $37 million charge to its loss reserves for fourth quarter 2019 due to “deteriorating loss experience, driven by a large national healthcare account.” On this news …

Follow Howard G. Smith:    

Henry Schein

DEADLINE ALERT for CVET, IRBT, UNIT, and SEE: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Globe Newswire | 11/19/2019

November 19, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on … that Covetrus had understated the costs of the integration of Henry Schein’s Animal Health Business and VFC, including the timing and nature of those costs; (3) that Covetrus had understated its separation costs from Henry …

electroCore

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against electroCore, Inc. | Globe Newswire | 11/14/2019

November 14, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Law Offices of Howard G. Smith reminds investors of the upcoming November 25, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired: a) electroCore, Inc. (“electroCore” or the “Company”) (NASDAQ: ECOR ) common stock pursuant and/or traceable to the registration statement and prospectus …

GeneSight

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Myriad Genetics, Inc. | Globe Newswire | 10/28/2019

October 28, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Oct. 28, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors of the upcoming November 26, 2019 deadline to … questioned the claims of marketed genetics tests, such as Myriad’s GeneSight. Myriad also disclosed that “the FDA requested changes to the GeneSight test offering” after Myriad had provided the FDA with clinical evidence and other …

Myriad Genetics

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Myriad Genetics, Inc. | Globe Newswire | 10/28/2019

October 28, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Oct. 28, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors of the upcoming November 26, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN ) securities between September 2, 2016 and August 13, 2019 , inclusive …

Food and Drug Administration

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against electroCore, Inc. | Globe Newswire | 10/25/2019

October 25, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors of the upcoming November 25, 2019 deadline to … on September 25, 2019, the Company revealed that the U.S. Food and Drug Administration requested more information and analysis of clinical data for electroCore’s 510(k) submission, which seeks an expanded indication for the use …

Clinical Data

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against electroCore, Inc. | Globe Newswire | 10/25/2019

October 25, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors of the upcoming November 25, 2019 deadline to … Food and Drug Administration requested more information and analysis of clinical data for electroCore’s 510(k) submission, which seeks an expanded indication for the use of gammaCore, the Company’s treatment for pain associated with episodic …

DXC Technology

DEADLINE ALERT for PUMP, DXC, OLLI, and FTCH: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Globe Newswire | 10/10/2019

October 10, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the … prospects, were materially misleading and/or lacked a reasonable basis. DXC Technology Company (NYSE: DXC ) Class Period: Pursuant and/or traceable to April 2017 Transaction by which Hewlett Packard Enterprise Company’s Enterprise Services segment was …

Curaleaf

DEADLINE ALERT for CURLF, TWOU, EVH, and IFF: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Globe Newswire | 10/2/2019

October 02, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Oct. 02, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on … class actions at 888-638-4847 or by email to [email protected] . Curaleaf Holdings, Inc. (OTC: CURLF )Class Period: November 21, 2018 and July 22, 2019Lead Plaintiff Deadline: October 4, 2019 The complaint filed in this class …

Passport Health Plan

DEADLINE ALERT for CURLF, TWOU, EVH, and IFF: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Financial Buzz | 10/2/2019

BENSALEM, Pa., Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to … partners such as University Health Care, Inc., d/b/a Passport Health Plan (“Passport”); (2) that Passport was struggling financially, particularly after Kentucky cut its reimbursement rates, and the partnership between Evolent and Passport was …

Cardinal Health

DEADLINE ALERT for CAH, PS, MDP, and GNLN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Globe Newswire | 9/30/2019

September 30, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Sept. 30, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on … class actions at 888-638-4847 or by email to [email protected] . Cardinal Health, Inc. (NYSE: CAH )Class Period: March 2, 2015 - May 2, 2018Lead Plaintiff Deadline: September 30, 2019 The complaint filed in this class action …

Aclaris Therapeutics

DEADLINE ALERT for ACRS, GTT, JE, and NKTR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Globe Newswire | 9/27/2019

September 27, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Sept. 27, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on … class actions at 888-638-4847 or by email to [email protected] . Aclaris Therapeutics, Inc. (NASDAQ: ACRS )Class Period: May 8, 2018 and June 20, 2019Lead Plaintiff Deadline: September 30, 2019 The complaint filed in this class …

Nektar Therapeutics

DEADLINE ALERT for ACRS, GTT, JE, and NKTR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Globe Newswire | 9/27/2019

September 27, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Sept. 27, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on … prospects were materially misleading and/or lacked a reasonable basis. Nektar Therapeutics. (NASDAQ: NKTR )Class Period: February 15, 2019 and August 8, 2019Lead Plaintiff Deadline: October 18, 2019 The complaint filed in this class action …

Evolent Health

DEADLINE ALERT for TWOU, EVH, IFF, and GVA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders | Globe Newswire | 9/24/2019

00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded … prospects were materially misleading and/or lacked a reasonable basis. Evolent Health, Inc. (NYSE: EVH ) Class Period: March 3, 2017 - May 28, 2019Lead Plaintiff Deadline: October 7, 2019 The complaint filed in this class action …

Aclaris

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aclaris Therapeutics, Inc. | Globe Newswire | 9/20/2019

September 20, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Law Offices of Howard G. Smith reminds investors of the upcoming September 30, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aclaris Therapeutics, Inc. (“Aclaris” or the “Company”) (NASDAQ: ACRS ) securities between May 8, 2018 and June 20, 2019 , inclusive (the “Class Period”). Investors suffering …

Oasmia Pharmaceutical

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Oasmia Pharmaceutical AB | Globe Newswire | 9/20/2019

September 20, 2019 11:00 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Sept. 20, Law Offices of Howard G. Smith reminds investors of the upcoming September 27, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) (NASDAQ: OASM ) securities between October 23, 2015 and July 9, 2019 , inclusive (the “Class Period …

BeiGene

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation on Behalf of BeiGene, Ltd. Investors (BGNE) | The Wapakoneta Daily News | 9/16/2019

Law Offices of Howard G. Smith continues its investigation on behalf of BeiGene, Ltd. (“BeiGene” or the “Company”) (NASDAQ: BGNE ) investors concerning the Company and its officers’ possible violations of federal securities laws. On September 5, 2019, J Capital Research published a report alleging, among other things, that BeiGene “is faking sales in order to persuade investors that it can develop a successful platform in China” and that “management may …

Karyopharm Therapeutics

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Karyopharm Therapeutics, Inc. | Globe Newswire | 9/16/2019

September 16, 2019 10:30 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Law Offices of Howard G. Smith reminds investors of the upcoming September 23, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Karyopharm Therapeutics, Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI ) investors that: (1) purchased shares of Karyopharm’s common stock between March 2, 2017 and February 22, 2019 , inclusive …

Omnicell

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Omnicell, Inc. | Globe Newswire | 9/11/2019

September 11, 2019 13:31 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Sept. 11, Law Offices of Howard G. Smith reminds investors of the upcoming September 16, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL ) securities between October 25, 2018 and July 11, 2019 , inclusive (the “Class Period”). Investors …

Novartis

INVESTOR ALERT: Law Offices of Howard G. Smith Continues its Investigation on Behalf of Novartis AG Investors (NVS) | Globe Newswire | 9/11/2019

September 11, 2019 13:44 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Sept. 11, Law Offices of Howard G. Smith continues its investigation on behalf of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS ) investors concerning the Company and its officers’ possible violations of federal securities laws. On August 6, 2019, the U.S. Food and Drug Administration (“FDA”) issued a statement revealing that data submitted in the Company’s …